Sino Biopharmaceutical Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG8167W1380
HKD
6.80
0.07 (1.04%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'21
Mar'21
Dec'20
Sep'20
Jun'20
Mar'20
Dec'19
Net Sales
8,550.94
8,671.95
6,458.61
6,136.73
7,026.83
6,927.84
5,457.35
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
8,550.94
8,671.95
6,458.61
6,136.73
7,026.83
6,927.84
5,457.35
Raw Material Cost
1,608.28
1,695.01
1,295.73
1,436.79
1,667.80
1,410.62
1,283.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
1,440.34
1,335.31
1,098.78
1,109.32
893.32
910.63
960.82
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
90.86
85.80
67.73
102.10
91.74
100.69
107.36
Selling and Distribution Expenses
3,831.89
4,303.63
3,598.25
3,538.83
2,526.94
3,249.39
2,917.67
Other Expenses
-60.88
-20.64
-34.80
-77.86
-36.53
7.30
-68.57
Total Expenditure (Excl Depreciation)
6,362.57
7,213.35
5,712.50
5,408.48
4,814.49
5,744.32
4,583.18
Operating Profit (PBDIT) excl Other Income
2188.4
1458.6000000000001
746.1
728.3
2212.2999999999997
1183.5
874.2
Other Income
277.92
275.28
23.07
486.03
-179.42
163.90
428.49
Operating Profit (PBDIT)
2,719.88
1,963.07
1,296.92
1,717.84
2,403.10
1,760.47
1,883.79
Interest
90.86
85.80
67.73
102.10
91.74
100.69
107.36
Exceptional Items
64.09
-13.92
689.71
267.48
-483.54
161.71
25.25
Gross Profit (PBDT)
6,942.67
6,976.94
5,162.87
4,699.95
5,359.03
5,517.22
4,174.36
Depreciation
253.59
229.19
527.74
503.55
370.18
413.05
581.12
Profit Before Tax
2,439.51
1,634.16
1,391.16
1,379.67
1,457.64
1,408.44
1,220.56
Tax
1,070.22
535.11
-123.19
268.64
356.09
236.33
63.52
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
7,896.83
2,291.01
1,076.84
714.07
383.89
959.83
501.25
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
7,896.83
2,291.01
1,076.84
714.07
383.89
959.83
501.25
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
818.14
575.79
535.17
345.96
669.90
212.27
655.79
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
8,714.97
2,866.80
1,612.01
1,060.02
1,053.78
1,172.10
1,157.04
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.03
0.03
0.03
0.03
Reserves
29,536.81
22,138.05
19,856.11
36,041.00
34,527.02
34,646.44
34,801.36
Earnings per share (EPS)
0.41
0.11
0.06
0.04
0.02
0.05
0.03
Diluted Earnings per share
0.41
0.11
0.06
0.04
0.02
0.05
0.03
Operating Profit Margin (Excl OI)
25.59%
16.82%
11.55%
11.87%
31.48%
17.08%
16.02%
Gross Profit Margin
31.49%
21.49%
29.71%
30.69%
26.01%
26.29%
33.01%
PAT Margin
92.35%
26.42%
16.67%
11.64%
5.46%
13.85%
9.18%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2021 is 21.69% vs -3.21% in Jun 2020

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2021 is 727.01% vs -20.68% in Jun 2020

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2021 is -5.44% vs 34.04% in Jun 2020

stock-summary

Interest

YoY Growth in quarter ended Jun 2021 is -0.87% vs 56.22% in Jun 2020

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2021 has fallen from Jun 2020

Compare Quarterly Results Of Sino Biopharmaceutical Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
8,550.94
0
8,550.94
Other Operating Income
0.00
0.00
0.00
Total Operating income
8,550.94
0
8,550.94
Raw Material Cost
1,608.28
0
1,608.28
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
1,440.34
0
1,440.34
Power Cost
0
0
0.00
Manufacturing Expenses
90.86
0
90.86
Selling and Distribution Expenses
3,831.89
0
3,831.89
Other Expenses
-60.88
0.00
-60.88
Total Expenditure (Excl Depreciation)
6,362.57
0
6,362.57
Operating Profit (PBDIT) excl Other Income
2,188.37
0.00
2,188.37
Other Income
277.92
0
277.92
Operating Profit (PBDIT)
2,719.88
0
2,719.88
Interest
90.86
0
90.86
Exceptional Items
64.09
0
64.09
Gross Profit (PBDT)
6,942.67
0
6,942.67
Depreciation
253.59
0
253.59
Profit Before Tax
2,439.51
0
2,439.51
Tax
1,070.22
0
1,070.22
Provisions and contingencies
0.00
0
0.00
Profit After Tax
7,896.83
0
7,896.83
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
7,896.83
0
7,896.83
Share in Profit of Associates
0.00
0
0.00
Minority Interest
818.14
0
818.14
Other related items
0.00
0.00
0.00
Consolidated Net Profit
8,714.97
0
8,714.97
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
29,536.81
0
29,536.81
Earnings per share (EPS)
0.41
0
0.41
Diluted Earnings per share
0.41
0
0.41
Operating Profit Margin (Excl OI)
25.59%
0%
0.00
25.59%
Gross Profit Margin
31.49%
0%
0.00
31.49%
PAT Margin
92.35%
0%
0.00
92.35%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 855.09 Million
in Jun 2021

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2021 is -1.40% vs 34.27% in Mar 2021

stock-summary

YoY Growth in quarter ended Jun 2021 is 21.69% vs -3.21% in Jun 2020

Quarterly - Consolidate Net Profit
Consolidate Net Profit 871.50 Million
in Jun 2021

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2021 is 204.00% vs 77.84% in Mar 2021

stock-summary

YoY Growth in quarter ended Jun 2021 is 727.01% vs -20.68% in Jun 2020

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 244.20 Million
in Jun 2021

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2021 is 44.69% vs 32.49% in Mar 2021

stock-summary

YoY Growth in quarter ended Jun 2021 is -5.44% vs 34.04% in Jun 2020

Quarterly - Interest
Interest 9.09 Million
in Jun 2021

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2021 is 5.94% vs 26.74% in Mar 2021

stock-summary

YoY Growth in quarter ended Jun 2021 is -0.87% vs 56.22% in Jun 2020

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 25.59%
in Jun 2021

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2021 has improved from Mar 2021

stock-summary

YoY Growth in quarter ended Jun 2021 has fallen from Jun 2020